Culture method for improving growth metabolism expression of CHO (Chinese hamster ovary) cells

Optimizing CHO cell culture through serum-free high expression medium and perfusion and feeding technology has solved the problems of low protein yield and lactic acid accumulation in CHO cell culture, improved cell density and protein expression, reduced production costs and enhanced process stability .

CN118956767AInactive Publication Date: 2024-11-15SHANGHAI DUONING BIOTECHNOLOGY CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411317322.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-20
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The protein yield in existing CHO cell culture is not high, and there are problems such as low cell density, low viability and lactic acid accumulation, which affects industrial production.

Method used

Using serum-free high-expression medium, including basal medium and organic acids, cell growth is optimized through passage operation and perfusion feeding techniques, controlling medium composition and DO values, ensuring nutrient supply and clearance of metabolites.

Benefits of technology

It improves the growth density and protein expression of CHO cells, enhances cell viability and antibody synthesis, reduces production costs, reduces lactic acid accumulation and batch differences, and improves the stability and repeatability of the process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956767A_ABST
    Figure CN118956767A_ABST
Patent Text Reader

Abstract

The invention discloses a culture method for improving growth, metabolism and expression of CHO cells, and relates to the technical field of cell culture, and the culture method comprises the following steps: S1, reviving cryopreserved CHOK1 cells in a high-expression culture medium; s2, carrying out passage operation once every 2-3 days, and keeping the cells in an early logarithmic phase; s3, when the cell density reaches 4.5-6.0 * 10 < 6 > cells / mL, the cell viability is greater than or equal to 95%, and the time interval is 2-3 days, performing passage again; s4, after three times of passage according to the steps S2 and S3, starting to inoculate, inoculating the cells into a high-expression culture medium, and culturing; s5, after culture, supplementing materials in batches by using a material supplementing culture medium; s6, culturing for 14-16 days, harvesting, and detecting the protein concentration; the CHO cell expression target protein can be facilitated, and the growth and expression of the CHO cell can be improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of cell culture, and in particular to a culture method for improving the growth and metabolic expression of CHO cells. Background Art

[0002] CHO cells, the full name of which is Chinese Hamster Ovary cells (CHO), were isolated from an adult female hamster ovary by Dr. Theodore T. Puck of the University of Colorado in 1957. They are currently one of the most widely used cell lines in bioengineering. The most commonly used CHO cell lines in industry are mainly divided into CHOK1, CHOK1SV, CHOZN, CHODG44, CHOS, etc. CHO cells are often used in bioengineering to prepare recombinant therapeutic proteins and monoclonal antibodies (mAbs), such as adalimumab and belotomab. Compared with other cell types, CHO cells have the advantages of (1) being able to grow stably in chemically defined and serum-free suspension cultures, (2) showing reasonable safety in terms of human pathogenic virus responses, and (3) being able to express post-translational modifications similar to those of humans.

[0003] The earliest in vitro cell culture medium is composed of serum (human or fetal bovine), plasma or tissue extract nutrient-like components. Its extraction process is complicated, the batch-to-batch stability is poor and the chemical composition is unclear. Ordinary CHO cell culture usually requires 10% fetal bovine serum, which increases the risk of contamination and is not conducive to protein purification in downstream processes. Therefore, the use of chemically determined, serum-free, and protein-free cell culture medium has a significant impact on actual industrial production. Summary of the invention

[0004] The embodiments of the present application provide a solution to the problem of low protein yield and lack of high-expression culture medium in the prior art, thereby increasing the growth and metabolic expression of CHO cells.

[0005] The present application embodiment provides a culture method for improving the growth and metabolic expression of CHO cells, which specifically includes: S1: Resuscitate the frozen CHOK1 cells in high expression medium and culture the cells in a shaker at 37°C, 8% carbon dioxide, and 110-130 rpm; S2: Perform subculturing every 2-3 days to keep the cells in the early logarithmic growth phase. The cell seeding density is 0.3-1.0-1.0×10 6 cells / mL; S3: When the cell density reaches 4.5-6.0×10 6 cells / mL, cell viability ≥95%, and subculture again after 2-3 days; S4: After three subcultures according to S2 and S3 methods, the cells were inoculated into high expression medium for culture; S5: Batch feeding using feed medium after cultivation; The mass of the feed medium each time accounts for 3-8% of the mass of the high expression medium; the feed is stopped 1-2 days before the end of the culture; S6: Harvest after 14-16 days of culture and detect protein concentration.

[0006] Furthermore, in step S4, the seeding density is 0.4-1.2×10 6 cells / mL, the shaker temperature was 36.5-37°C, and the rotation speed was 130±20 rpm.

[0007] Furthermore, in step S4, the CO2 concentration in the incubator is set to 5%-10%, the culture temperature is 36.5-37°C, the initial rotation speed is 180±20 rpm, and the pH is set to 7.0±0.3.

[0008] Furthermore, the DO value was set to 40% during the culture process.

[0009] Furthermore, the components of the high expression culture medium include: basal culture medium and organic acid.

[0010] Furthermore, the basal culture medium is a commercially available basal culture medium.

[0011] Furthermore, the organic acid includes: a combination of 2-4 organic acids selected from α-ketoglutaric acid, malic acid, fumaric acid, and succinic acid, with specific concentrations being: α-ketoglutarate 0.5-5.0 mM; Malic acid 0.6-6.0 mM; Fumaric acid 0.5-5.0 mM; Succinic acid 0.5-5.0 mM.

[0012] Furthermore, on the 6th and 10th days of culture, a cell retention device is used to perform perfusion feeding culture using a perfusion medium, wherein the perfusion medium includes a high expression medium and a feeding medium, and the mass ratio of the high expression medium to the feeding medium is 8:2; 5% of the total volume of the culture medium is replaced every hour, and no feeding is performed on the 6th to 10th days.

[0013] Furthermore, on the 6th and 10th days, the DO value was reduced to 15% while the perfusion culture medium was used for perfusion feeding culture using a cell retention device; and it returned to a normal level after the perfusion was completed.

[0014] Furthermore, the DO value was increased to 50% and maintained for 6 h before being reduced to 10% before the perfusion was started.

[0015] One or more technical solutions provided in the embodiments of the present application have at least the following technical effects or advantages: First, the serum-free culture medium for culturing CHO cells provided by the present invention is conducive to the expression of target proteins by CHO cells, and improves the growth and expression of CHO cells; using the optimized culture medium of the present invention, in terms of growth, the cell peak density can reach 21.1×106 cells / mL, the harvest viability after 14 days of culture can be increased to 91.89%, lactic acid is 0g / L, and the expression amount can reach 7633mg / L; without changing the solubility of the culture medium, by adding mixed organic acids, taking cell growth, metabolism, and protein expression as evaluation indicators, the best organic acid substance type and concentration combination in the culture medium are found, which solves the problems of low cell density, low viability, lactic acid accumulation, low protein yield, etc. in the cell culture process, which not only reduces the enterprise cost, but also reduces the technical problems caused by lactic acid accumulation in the actual industrial production process.

[0016] Second, perfusion feeding is used on the 6th and 10th days. The cells are separated from the culture medium through a cell retention device, and fresh culture medium is continuously replaced. This method can continuously provide sufficient nutrition to the cells and avoid the accumulation of metabolites that are toxic to the cells, thereby maintaining the continuous growth of cells at high density. Perfusion feeding technology ensures the continuous supply of nutrients in the culture medium, especially amino acids, vitamins and trace elements that are closely related to antibody synthesis, thereby supporting the efficient synthesis of antibodies. By optimizing cell growth and antibody expression conditions, the culture cycle can be shortened and the yield per unit volume can be increased, thereby reducing production costs. Perfusion feeding technology helps to reduce the accumulation of metabolic byproducts and may improve the purity and biological activity of antibodies; by precisely controlling the composition of the culture medium and the perfusion rate, batch differences can be reduced and the stability and repeatability of the process can be improved.

[0017] Third, lowering the DO value may temporarily inhibit the rapid proliferation of cells, causing the cells to enter a state of relative stillness or slow proliferation, which helps to reduce the problems of malnutrition and accumulation of metabolic waste caused by excessive proliferation, and reduce the impact of changes in the culture environment caused by perfusion on cells; enabling cells to better cope with the mechanical stress and changes in nutritional conditions caused by perfusion, and maintain the health of cells; after the perfusion is completed, the DO value is restored to normal levels, and the cells can use the fresh nutrients and growth factors provided by the perfusion feed to quickly recover and accelerate proliferation.

[0018] Fourth, maintaining a relatively high DO level first allows cells to proliferate rapidly and reach an optimal growth state, and then gradually lowers the DO value, which can allow cells to gradually adapt to the low oxygen environment, stimulate the cells' stress resistance response, enhance antioxidant capacity, and promote the transformation of energy metabolism pathways. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 The cell viability density of cells in 125 mL shake flask in basal medium changes over time (10 6 cells / mL); Figure 2 Cell viability in 125 mL shake flask in basal medium over time (%); Figure 3 Diagram of cell diameter changes over time in 125 mL shake flasks in basal medium (μm); Figure 4 Glucose metabolism of cells in 125 mL shake flasks in basal medium over time (g / L); Figure 5 The change of lactate metabolism of cells in 125mL shake flask in basal medium over time (g / L); Figure 6 The change of antibody protein concentration over time (mg / L) was detected by Cedex method in a shake flask with cells in basal culture medium. DETAILED DESCRIPTION

[0020] To facilitate the understanding of the present invention, the present application will be described more comprehensively below with reference to the relevant drawings; the drawings show preferred embodiments of the present invention, but the present invention can be implemented in many different forms and is not limited to the embodiments described herein; on the contrary, the purpose of providing these embodiments is to enable a more thorough and comprehensive understanding of the disclosed content of the present invention.

[0021] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by technicians in the technical field to which the present invention belongs; the terms used in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention; the term "and / or" used herein includes any and all combinations of one or more related listed items.

[0022] Embodiment 1

[0023] A method for improving the growth and metabolic expression of CHO cells, comprising: S1: Resuscitate the frozen CHOK1 cells in high expression medium and culture the cells in a shaker at 37°C, 8% carbon dioxide, and 110-130 rpm; S2: Perform subculture every 2-3 days to keep the cells in the early logarithmic growth phase, and the cell seeding density is 0.3-1.0-1.0×106cells / mL; S3: When the cell density reaches 4.5-6.0×106 cells / mL and the cell viability is ≥95%, the cells are passaged again after an interval of 2-3 days; S4: After three subcultures according to S2 and S3 methods, the cells were inoculated into high expression medium for culture; Among them, the inoculation density is 0.4-1.2×106cells / mL, the temperature of the shaker is 36.5-37℃, the rotation speed is 130±20rpm, the CO2 concentration in the incubator is set to 5%-10%, the culture temperature is 36.5-37℃, the initial rotation speed is 180±20rpm, the pH is set to 7.0±0.3, and the DO is set to 40%; S5: Batch feeding using feed medium after cultivation; The mass of the feed medium each time accounts for 3-8% of the mass of the high expression medium; the feed is stopped 1-2 days before the end of the culture; S6: harvested on day 14-16 of culture and protein concentration tested; The components of the high expression culture medium include: a basic culture medium and an organic acid; The basal culture medium is a commercially available basal culture medium that can be purchased from companies such as Sigma and GIBCO; The organic acid includes: a combination of 2 to 4 organic acids selected from α-ketoglutaric acid, malic acid, fumaric acid, and succinic acid; The feed medium is a commercially available feed medium that can be purchased from companies such as Sigma; The technical solutions in the above embodiments of the present application have at least the following technical effects or advantages: The serum-free culture medium for culturing CHO cells provided by the present invention is conducive to the expression of target proteins by CHO cells, and improves the growth and expression of CHO cells. By using the optimized culture medium of the present invention, in terms of growth, the cell peak density can reach 21.1×106 cells / mL, the harvest viability after 14 days of culture can be increased to 91.89%, the lactic acid is 0 g / L, and the expression amount can reach 7633 mg / L. Under the premise of not changing the solubility of the culture medium, by adding mixed organic acids, taking cell growth, metabolism, and protein expression as evaluation indicators, the best organic acid substance type and concentration combination in the culture medium are found, which solves the problems of low cell density, low viability, lactic acid accumulation, low protein yield, etc. in the cell culture process, not only reduces the enterprise cost, but also reduces the technical problems caused by lactic acid accumulation in the actual industrial production process. Organic acids participate in the tricarboxylic acid cycle of cells. The tricarboxylic acid cycle is a metabolic pathway that is prevalent in aerobic organisms. This process not only provides raw materials for the synthesis of biological molecules, but also releases a large amount of ATP to provide energy for various biochemical reactions. The tricarboxylic acid cycle has important biological significance. In the in vitro cell culture process, the additional addition of organic acids, which are intermediate products in the tricarboxylic acid cycle, can improve the growth and metabolic state of industrial cells and increase cell protein expression.

[0024] The specific experiment was as follows: a CHOK1 cell cryopreservation tube was taken from a liquid nitrogen tank, shaken and dissolved in a 37°C water bath, and added to a 125mL shake flask containing 20mL of high expression culture medium and mixed. Subsequently, the cells were cultured in a shaker at 120rpm, 8% CO2, and 37°C; the cells were subcultured every 2 days to keep them in the early logarithmic growth phase, and the cell seeding density was 1.0×10 6 cells / mL; when the cell density reaches 7×10 6 cells / mL, cell viability ≥ 95%, and then subculture again after 3 days; after 3 subcultures, the cells were inoculated after the population doubling time stabilized, the culture time was D0, and the inoculation density was 0.965×10 6 cells / mL, inoculated into 125mL shake flask. The culture temperature was set to 37°C, CO2 was set to 8%, shaker humidity was set to 80%, and shaker speed was set to 120rpm. Samples were taken every 2 days during the culture process and counted using a Countstar counter. Each sample was counted three times, and the cell survival rate was determined by trypan blue staining. Metabolic detection was performed using an M100 biochemical analyzer. After culture, batch feeding was performed using a combined feeding medium of DN feed 3+DN feed B3, with 5% feeding every two days until 2 days before the end of the culture. The experimental culture was harvested on the 14th day, and antibody concentration was tested using Cedex.

[0025] The organic acids in the high expression medium include high concentration and low concentration respectively; specifically: α-ketoglutarate high concentration 5.0 mM, low concentration 0.5 mM; Malic acid high concentration 6.0 mM, low concentration 1.0 mM; Fumaric acid high concentration 5.0 mM, low concentration 0.5 mM; Succinic acid high concentration 5.0 mM, low concentration 0.5 mM; The experimental scheme was set up using Minitab for partial factorial analysis. The combinations not involved in the running sequence were mixed with 2-3 substances at low concentrations. The cell culture scheme and results are shown in Tables 1, 2, 3, 4, 5, 6, and 7. The key combinations are as follows Figure 1 , 2 , 3, 4, 5, 6 as shown: Table 1 Main implementation plan for cell culture Shake bottle number Basic culture medium α-Ketoglutarate Malic Acid Fumaric Acid Succinic acid Example 1 Media C-05 L L L L Example 2 Media C-05 L H H L Example 3 Media C-05 H L L H Example 4 Media C-05 H H L L Example 5 Media C-05 L H L H Example 6 Media C-05 L L H H Example 7 Media C-05 H L H L Example 8 Media C-05 H H H H Example 9 Media C-05 L L / / Example 10 Media C-05 L / L / Example 11 Media C-05 L / / L Example 12 Media C-05 / L L / Example 13 Media C-05 / L / L Example 14 Media C-05 / / L L Example 15 Media C-05 L L L / Example 16 Media C-05 L L / L Example 17 Media C-05 L / L L Example 18 Media C-05 / L L L Comparison Example Media C-05 / / / / Table 2 Live cell density in 125 mL shake flask (×10 6 cells / mL) over time Cultivation time / day 0 2 4 6 8 10 12 14 Example 1 0.965 5.03 15.4 18.3 16.4 12.6 10.2 7.8 Example 2 0.965 4.98 14.3 19.5 14.5 13.4 12.3 11.1 Example 3 0.965 4.87 16.5 21.1 16.5 15.4 13.8 12 Example 4 0.965 5.25 15.2 18.1 13.2 12.7 11.1 9.76 Example 5 0.965 5.22 15.6 20 16.1 15.7 14.4 12.5 Example 6 0.965 4.7 15.4 20.2 15.5 14.1 13.9 11.1 Example 7 0.965 4.88 14.3 17.3 12.1 12.1 10.1 7.72 Example 8 0.965 4.69 13.3 17.3 11.4 12.1 11 9.07 Example 9 0.965 4.7 14.5 18.5 12.7 12.2 9.65 8.33 Example 10 0.965 5.1 15 17.9 14.8 13.7 11.6 9.91 Example 11 0.965 5.08 15.1 17.2 9.88 10.3 9.22 9.14 Example 12 0.965 5.1 14.1 16.9 13.9 9.96 8.44 7.76 Example 13 0.965 5.24 14.3 18 18.5 11 9.49 8.13 Example 14 0.965 4.89 16.1 18.4 14.5 12.1 10.4 9.41 Example 15 0.965 4.87 15.4 17.8 13.7 11.4 10.2 8.37 Example 16 0.965 4.78 15.8 20.1 16.3 12.9 12.6 10.7 Example 17 0.965 4.58 14.4 18 11.9 10.5 8.18 8.23 Example 18 0.965 4.99 14.8 18.6 13.4 12.1 10.5 9.23 Comparison Example 0.965 5.02 13.9 17.3 13.2 10.2 9.54 8.39 Table 3 Trend of viability of live cells (%) in 125 mL shake flask over time Cultivation time / day 0 2 4 6 8 10 12 14 Example 1 97.89 99.13 98.92 95.77 92.05 90.8 86.83 79.73 Example 2 97.89 99.48 98.94 97.25 94.64 94.77 90.19 87.07 Example 3 97.89 99.42 98.92 97.74 95.89 95.96 91.89 86.64 Example 4 97.89 99.7 99.17 95.67 92.96 92.5 86.45 81.38 Example 5 97.89 99.21 99.26 97.51 96.84 96.66 92.73 88.91 Example 6 97.89 99.23 99.13 96.78 96.01 93.31 91.52 87.03 Example 7 97.89 99.52 98.69 95.64 88.95 82.53 76.68 73.61 Example 8 97.89 98.96 98.05 95.44 93.22 87.2 84.77 78.16 Example 9 97.89 98.96 99.19 96.31 92.12 86.21 87.22 76.79 Example 10 97.89 99.59 98.71 97.87 94.51 89.9 90.8 82.45 Example 11 97.89 99.64 99.16 95.06 88.5 86.87 83.25 69.47 Example 12 97.89 99.24 99.01 95.77 85.44 80.99 77.87 70.83 Example 13 97.89 99.26 98.56 95.16 87.23 86.34 81.82 71.89 Example 14 97.89 99.52 99.01 95.44 92.92 91.41 85.36 78.09 Example 15 97.89 99.31 98.91 96.13 93.17 89.85 84.69 74.92 Example 16 97.89 98.92 98.79 97.08 89.53 91.93 87.03 76.79 Example 17 97.89 99.1 98.54 95.17 90.57 85.55 77.97 71.34 Example 18 97.89 99.38 98.94 96.63 90.86 89.22 85.08 70.67 Comparison Example 97.89 99.28 97.7 96.47 90.88 85.85 77.65 68.26 Table 4 Trend of cell diameter (μm) over time in 125 mL shake flask Cultivation time / day 0 2 4 6 8 10 12 14 Example 1 14.23 14.55 14.52 15.34 16.69 17.82 18.43 18.97 Example 2 14.23 14.51 14.56 15.29 16.72 17.95 18.49 19.12 Example 3 14.23 14.69 14.45 15.22 16.72 17.79 18.49 18.75 Example 4 14.23 14.6 14.41 15.4 16.77 17.94 18.45 18.76 Example 5 14.23 14.65 14.53 15.33 16.67 17.94 18.55 18.82 Example 6 14.23 14.63 14.55 15.21 16.75 17.97 18.59 18.96 Example 7 14.23 14.49 14.54 15.32 16.69 17.75 18.14 18.6 Example 8 14.23 14.52 14.72 15.26 16.92 18.08 18.55 18.84 Example 9 14.23 14.46 14.52 15.25 16.86 17.86 18.5 18.63 Example 10 14.23 14.63 14.69 15.2 16.68 17.79 18.54 18.87 Example 11 14.23 14.52 14.5 15.28 16.71 17.82 18.2 18.33 Example 12 14.23 14.53 14.58 15.22 16.9 17.78 18.07 18.32 Example 13 14.23 14.51 14.67 15.2 16.84 17.88 18.38 18.53 Example 14 14.23 14.8 14.45 15.3 16.8 17.94 18.38 18.62 Example 15 14.23 14.68 14.54 15.29 16.74 17.95 18.45 18.72 Example 16 14.23 14.6 14.58 15.28 16.74 18.06 18.49 18.63 Example 17 14.23 14.66 14.59 15.21 16.74 18.02 18.37 18.52 Example 18 14.23 14.75 14.58 15.25 16.63 17.91 18.42 18.51 Comparison Example 14.23 14.63 14.51 15.15 16.43 17.6 17.87 18.15 Table 5 Glucose metabolism (g / L) in 125 mL shake flasks over time Cultivation time / day 2 4 6 8 10 12 14 Example 1 3.02 6.59 7.96 8.33 6.87 7.84 6.86 Example 2 3.02 6.8 8.13 8.61 6.98 7.44 6.01 Example 3 2.92 6.47 7.6 7.78 6.47 5.9 5.9 Example 4 3 6.68 8.03 8.5 7.55 7.03 6.01 Example 5 2.95 6.48 7.65 7.89 6.45 5.98 5.99 Example 6 2.98 6.62 7.82 8.25 6.94 6.62 5.92 Example 7 3.01 6.72 8.11 8.81 8.14 7.91 7.49 Example 8 2.82 7.05 8.9 9.35 8.53 7.71 6.83 Example 9 2.8 7.1 8.65 9.21 8.41 8.01 6.3 Example 10 2.75 7.04 7.74 8.21 6.98 6.94 6.53 Example 11 2.77 6.89 7.74 8.34 7.45 7.11 6.39 Example 12 2.76 7.04 7.86 8.61 8.05 7.64 9.47 Example 13 2.75 7.19 7.63 8.36 7.61 7.31 6.57 Example 14 2.78 7.11 7.79 8.26 6.95 6.8 6.48 Example 15 2.8 7.28 8.02 8.58 7.42 6.93 6.73 Example 16 2.78 7.14 7.79 8.32 7.15 6.35 5.97 Example 17 2.73 7.13 7.95 8.66 7.8 7.43 6.79 Example 18 2.75 7.03 7.68 8.53 7.12 6.84 6.45 Comparison Example 2.96 7.8 8.68 11.22 11.11 8.71 7.08 Table 6 Trend of lactate metabolism (g / L) over time in 125 mL shake flasks Cultivation time / day 2 4 6 8 10 12 14 Example 1 1.25 1.34 0.42 0.31 0.19 0.08 0.1 Example 2 1.23 1.33 0.43 0.14 0.09 0.07 0.08 Example 3 1.26 1.44 0.54 0.18 0.06 0.02 0 Example 4 1.26 1.33 0.55 0.35 0.37 0.28 0.23 Example 5 1.25 1.43 0.58 0.2 0.12 0.04 0.03 Example 6 1.22 1.41 0.61 0.2 0.14 0.08 0.06 Example 7 1.21 1.35 0.59 0.31 0.56 0.48 0.55 Example 8 1.27 0.69 0.76 0.25 0.54 0.42 0.4 Example 9 1.18 1.2 0.43 0.18 0.43 0.28 0.33 Example 10 1.16 1.29 0.46 0.15 0.26 0.11 0.15 Example 11 1.15 1.3 0.49 0.22 0.26 0.29 0.37 Example 12 1.18 1.28 0.6 0.3 0.62 0.54 0.97 Example 13 1.17 1.47 0.47 0.19 0.27 0.27 0.28 Example 14 1.13 1.4 0.43 E 0.21 0.36 0.34 Example 15 1.15 1.36 0.46 0.07 0.26 0.39 0.4 Example 16 1.14 1.37 0.45 0.1 0.14 0.34 0.3 Example 17 1.14 1.33 0.49 0.12 0.36 0.6 0.58 Example 18 1.16 1.31 0.44 0.33 0.23 0.44 0.48 Comparison Example 1.37 0.83 0.47 0 0 0.27 0.4 Table 7 Trend of protein expression (mg / L) in 125mL shake flask over time Cultivation time / day 12 14 Example 1 5717 6540 Example 2 6072 7084 Example 3 5611 6800 Example 4 5856 6910 Example 5 6225 7259 Example 6 6116 7133 Example 7 5494 6734 Example 8 5600 6880 Example 9 5484 7197 Example 10 6094 7552 Example 11 5600 6902 Example 12 5547 7151 Example 13 5463 6823 Example 14 5717 7026 Example 15 5717 7162 Example 16 5932 7402 Example 17 5306 6478 Example 18 5997 7633 Comparison Example 5921 7004 Tables 1, 2, 3, 4, 5, 6, 7 and Figure 1 , 2 The results of 3, 4, 5, and 6 showed that the final cell peak density of cells in high expression medium could reach 21.1×10 6 cells / mL; the cell viability at D14 was 91.89%; lactic acid showed a trend of accumulation first and then consumption, and there was no lactic acid recovery during the entire culture process. The lactic acid concentration at D14 was 0g / L; the protein yield at D14 could reach 7633mg / Lmg / L. In the control group, using the above process, the cell peak density during the entire culture process was 17.3×10 6 cells / mL, D14 cell viability was 68.26%, D14 lactic acid concentration was 0.40g / L, and D14 protein production was 7004mg / L. This shows that the high expression medium has a significant effect on improving cell growth, metabolism, and expression, and further improves cell viability in the later stage and increases cell protein expression.

[0026] Embodiment 2 In the above-mentioned embodiment 1, organic acids are added to the basal culture medium to increase the metabolism of cells, and perfusion culture is introduced to maintain the best growth environment of cells and improve the protein expression efficiency, which is an improvement on the basis of embodiment 1.

[0027] On the 6th and 10th days, perfusion feeding culture was performed using a cell retention device using a perfusion medium, wherein the perfusion medium included a high expression medium and a feed medium, and the mass ratio of the high expression medium to the feed medium was 8:2; 5% of the total volume of the culture medium was replaced every hour, and no feeding was performed on the 6th to 10th days.

[0028] The technical solutions in the above embodiments of the present application have at least the following technical effects or advantages: Perfusion feeding is used on the 6th and 10th days. The cells are separated from the culture medium through a cell retention device, and fresh culture medium is continuously replaced. This method can continuously provide sufficient nutrients to the cells and avoid the accumulation of metabolites that are toxic to the cells, thereby maintaining the continuous growth of cells at high density. Perfusion feeding technology ensures the continuous supply of nutrients in the culture medium, especially amino acids, vitamins and trace elements that are closely related to antibody synthesis, thereby supporting the efficient synthesis of antibodies. By optimizing cell growth and antibody expression conditions, the culture cycle can be shortened and the yield per unit volume can be increased, thereby reducing production costs. Perfusion feeding technology helps to reduce the accumulation of metabolic byproducts and may improve the purity and biological activity of antibodies; by precisely controlling the composition of the culture medium and the perfusion rate, batch-to-batch differences can be reduced and the stability and repeatability of the process can be improved; Through the detection of Example 1, it was found that the growth state and metabolic state of cells changed greatly between 6 and 10 days, so perfusion on the 6th and 10th days could greatly optimize the expression of cell growth; based on the addition of 4 high-concentration organic acids, the antibody expression level could be increased to 6839 mg / L.

[0029] Embodiment 3 Example 2 The growth environment of cells is improved by perfusion culture to further increase the expression level of cells. In order to increase the adaptability of cells after perfusion culture, further improvements are made on the basis of Example 2.

[0030] On the 6th and 10th days, the DO value was reduced to 15% while the perfusion medium was used for perfusion feeding culture using a cell retention device; it returned to normal levels after the perfusion was completed.

[0031] The technical solutions in the above embodiments of the present application have at least the following technical effects or advantages: DO value (dissolved oxygen concentration) is a key parameter of cellular respiration, which directly affects the energy metabolism of cells. A short-term decrease in DO may trigger the metabolic stress response of cells, promote the redistribution of internal resources of cells, enhance the adaptability and survival ability of cells, and temporarily increase the metabolic capacity. Changes in DO value regulate the expression of genes related to growth, metabolism and antibody expression by affecting the intracellular redox state, energy level or signal transduction pathway. Lowering the DO value may temporarily inhibit the rapid proliferation of cells, causing the cells to enter a state of relative quiescence or slow proliferation, which helps to reduce the problems of malnutrition and accumulation of metabolic waste caused by excessive proliferation, and reduce the impact of changes in the culture environment caused by perfusion on the cells; enabling cells to better cope with the mechanical stress and changes in nutritional conditions caused by perfusion, and maintain the health of cells; after the perfusion is completed, the DO value is restored to normal levels, and the cells can use the fresh nutrients and growth factors provided by the perfusion feed to quickly recover and accelerate proliferation.

[0032] Cells whose DO values ​​were adjusted showed higher antibody expression ability after recovery. Metabolic stress promoted the transcription and translation of genes related to antibody synthesis. Changes in DO values ​​also affected post-translational modification processes such as antibody glycosylation, thereby affecting the structure and functional properties of antibodies. In some cases, this change produces antibodies of higher quality or with specific properties.

[0033] By optimizing the DO value control strategy, the biomass and antibody yield of cell culture can be increased without increasing production costs. Dynamic DO value control helps cells better adapt to various changes in the perfusion feeding process and improves the stability and repeatability of the process. Based on the addition of 4 high-concentration organic acids, the antibody expression level can be increased to 7397 mg / L.

[0034] Embodiment 4 Example 3: Hypoxia is used to reduce environmental changes caused by perfusion to reduce damage to cells. In order to further optimize the change of DO value, improvements are made on the basis of Example 3.

[0035] Before perfusion, the DO value was raised to 50%, maintained for 6 h, and then reduced to 10% before perfusion began.

[0036] The technical solutions in the above embodiments of the present application have at least the following technical effects or advantages: First, maintain a high DO level to allow cells to proliferate rapidly and reach the optimal growth state, and then gradually reduce the DO value, so that cells can gradually adapt to the low oxygen environment, stimulate the cell's stress resistance response, enhance antioxidant capacity, and promote the transformation of energy metabolism pathways. In a hypoxic environment, cells are more inclined to obtain energy through anaerobic glycolysis, reduce the production of reactive oxygen species (ROS), and reduce the damage of oxidative stress to cells. At the same time, hypoxia can also promote the expression of genes related to energy metabolism and optimize the energy utilization efficiency of cells. The reduction of DO value may affect the progress of cell cycle, prompting cells to shift from proliferation phase to resting phase or differentiation phase, and reduce cell apoptosis caused by excessive proliferation. In addition, hypoxia may also inhibit cell apoptosis by regulating the expression of apoptosis-related genes, thereby improving cell survival rate. By adjusting the DO value in stages, we can promote high-density cell growth while ensuring cell survival rate. High-density cell culture is not only conducive to increasing the total yield of antibodies, but also helps to reduce culture volume and production costs. The low-oxygen environment optimizes the energy metabolism and gene expression patterns of cells, thereby increasing the expression and stability of antibodies. By fine-tuning the DO value, unnecessary energy consumption and raw material waste can be reduced. At the same time, high-density cell culture and efficient antibody expression can also help shorten the production cycle and improve production efficiency, thereby reducing overall production costs. The strategy of adjusting the DO value in stages makes the cell culture process more controllable and predictable, helping to maintain consistency and stability between different batches of products.

[0037] Based on the addition of four high-concentration organic acids, the antibody expression level can be increased to 7412 mg / L.

[0038] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for improving the growth and metabolic expression of CHO cells, characterized in that: Specifically include: S1: Resuscitate the frozen CHOK1 cells in high expression medium and culture the cells in a shaker at 37°C, 8% carbon dioxide, and 110-130 rpm; S2: Perform subculturing every 2-3 days to keep the cells in the early logarithmic growth phase. The cell seeding density is 0.3-1.0-1.0×10 6 cells / mL; S3: When the cell density reaches 4.5-6.0×10 6 cells / mL, cell viability ≥95%, and subculture again after 2-3 days; S4: After three subcultures according to S2 and S3 methods, the cells were inoculated into high expression medium for culture; S5: Batch feeding using feed medium after cultivation; The mass of the feed medium each time accounts for 3-8% of the mass of the high expression medium; the feed is stopped 1-2 days before the end of the culture; S6: Harvest after 14-16 days of culture and detect protein concentration.

2. A method for improving the growth and metabolic expression of CHO cells according to claim 1, characterized in that: In step S4, the seeding density is 0.4-1.2×10 6 cells / mL, the shaker temperature was 36.5-37°C, and the rotation speed was 130±20 rpm.

3. The method for improving the growth and metabolic expression of CHO cells according to claim 1, characterized in that: In step S4, the CO2 concentration in the incubator is set to 5%-10%, the culture temperature is 36.5-37°C, the initial rotation speed is 180±20 rpm, and the pH is set to 7.0±0.

3.

4. The method for improving the growth and metabolic expression of CHO cells according to claim 1, characterized in that: The DO value was set at 40% during the culture process.

5. The method for improving the growth and metabolic expression of CHO cells according to claim 1, characterized in that: The components of the high expression culture medium include: basic culture medium and organic acid.

6. A method for improving the growth and metabolic expression of CHO cells as claimed in claim 5, characterized in that: The basal medium was commercially available.

7. A method for improving the growth and metabolic expression of CHO cells as claimed in claim 5, characterized in that: The organic acid includes: a combination of 2-4 organic acids selected from α-ketoglutaric acid, malic acid, fumaric acid, and succinic acid, with specific concentrations being: α-ketoglutarate 0.5-5.0 mM; Malic acid 0.6-6.0 mM; Fumaric acid 0.5-5.0 mM; Succinic acid 0.5-5.0 mM.

8. A method for improving the growth and metabolic expression of CHO cells as claimed in claim 7, characterized in that: On the 6th and 10th days of culture, perfusion feeding culture was performed using a cell retention device using a perfusion medium, wherein the perfusion medium included a high expression medium and a feed medium, and the mass ratio of the high expression medium to the feed medium was 8:2; 5% of the total volume of the culture medium was replaced every hour, and no feeding was performed on the 6th to 10th days.

9. A method for improving the growth and metabolic expression of CHO cells as claimed in claim 8, characterized in that: On the 6th and 10th days, the DO value was reduced to 15% while the perfusion medium was used for perfusion feeding culture using a cell retention device; it returned to normal levels after the perfusion was completed.

10. A method for improving the growth and metabolic expression of CHO cells according to claim 9, characterized in that: Before lowering the DO value, the DO value was raised to 50% and maintained for 6 h, then lowered to 10% before starting the perfusion.

Citation Information

Patent Citations

  • Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts

    CN106795548A

  • Method and culture medium for producing human follicle stimulating hormone through high-density perfusion culture of recombinant CHO cells and application of human follicle stimulating hormone

    CN110042137A

  • Serum-free culture medium suitable for high-density culture of insect cells and high expression of products

    CN114250191A